Last reviewed · How we verify
Kapilon (menadoxime)
Kapilon (generic name: menadoxime) is a menadoxime drug. It is currently in unknown development.
Kapilon works by inhibiting the enzyme acetylcholinesterase, which breaks down the neurotransmitter acetylcholine.
Kapilon, also known as menadoxime, is a small molecule drug in the menadoxime class. Its exact target and mechanism of action are unknown, but it is believed to work by inhibiting acetylcholinesterase, an enzyme that breaks down acetylcholine, a neurotransmitter involved in muscle contraction and other functions. Kapilon's commercial status and approved indications are unclear, and it is not known whether it is patented or available as a generic medication. Further research is needed to fully understand Kapilon's properties and potential uses. As a result, key safety considerations and pharmacokinetic parameters, such as half-life and bioavailability, are also unknown.
At a glance
| Generic name | menadoxime |
|---|---|
| Drug class | menadoxime |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Think of acetylcholine like a key that unlocks muscles to make them move. When acetylcholine is broken down too quickly, it can't do its job properly. Kapilon helps by slowing down the breakdown of acetylcholine, so it can keep unlocking muscles and helping them function.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Kapilon CI brief — competitive landscape report
- Kapilon updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Kapilon
What is Kapilon?
How does Kapilon work?
What is the generic name of Kapilon?
What drug class is Kapilon in?
What development phase is Kapilon in?
Related
- Drug class: All menadoxime drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing